Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th Annual Meeting of the ASGCT.
Overview A US biotech company's Phase I oncology study had stalled under the management of…
Overview A US biotech company's Phase I oncology study had stalled under the management of…